Santhera Pharmaceuticals Holding AG (SANN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.199x

Based on the latest financial reports, Santhera Pharmaceuticals Holding AG (SANN) has a cash flow conversion efficiency ratio of 1.199x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-14.16 Million ≈ $-17.91 Million USD) by net assets (CHF-11.82 Million ≈ $-14.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Santhera Pharmaceuticals Holding AG's balance sheet to measure how much of total assets are equity-financed.

Santhera Pharmaceuticals Holding AG - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Santhera Pharmaceuticals Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Santhera Pharmaceuticals Holding AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Santhera Pharmaceuticals Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Santhera Pharmaceuticals Holding AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Landmark Cars Limited NSE:LANDMARK	0.303x
Dimand S.A. AT:DIMAND	N/A
Monogram Orthopaedics Inc. Common Stock NASDAQ:MGRM	-0.267x
Zura Bio Limited Class A Ordinary Shares NASDAQ:ZURA	-0.130x
Formosan Rubber Group Inc TW:2107	0.014x
Xingguang Agricultural Mach SHG:603789	-0.127x
BROOGE ENERGY DL-0001 F:3SF	N/A
BTB Real Estate Investment Trust TO:BTB-UN	0.024x

Annual Cash Flow Conversion Efficiency for Santhera Pharmaceuticals Holding AG (2006–2025)

The table below shows the annual cash flow conversion efficiency of Santhera Pharmaceuticals Holding AG from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SANN company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.82 Million ≈ $-14.94 Million	CHF-34.76 Million ≈ $-43.95 Million	2.942x	+329.37%
2024-12-31	CHF27.70 Million ≈ $35.02 Million	CHF-35.53 Million ≈ $-44.92 Million	-1.283x	-262.65%
2023-12-31	CHF59.94 Million ≈ $75.78 Million	CHF47.27 Million ≈ $59.76 Million	0.789x	+15.44%
2022-12-31	CHF-43.69 Million ≈ $-55.23 Million	CHF-29.84 Million ≈ $-37.73 Million	0.683x	+102.43%
2021-12-31	CHF1.33 Million ≈ $1.68 Million	CHF-37.36 Million ≈ $-47.23 Million	-28.132x	-510.82%
2020-12-31	CHF-6.35 Million ≈ $-8.03 Million	CHF-43.51 Million ≈ $-55.01 Million	6.848x	+5506.63%
2019-12-31	CHF21.25 Million ≈ $26.86 Million	CHF2.60 Million ≈ $3.28 Million	0.122x	+108.98%
2018-12-31	CHF27.83 Million ≈ $35.18 Million	CHF-37.87 Million ≈ $-47.87 Million	-1.361x	-10.74%
2017-12-31	CHF32.26 Million ≈ $40.78 Million	CHF-39.63 Million ≈ $-50.11 Million	-1.229x	-236.64%
2016-12-31	CHF74.35 Million ≈ $94.00 Million	CHF-27.14 Million ≈ $-34.31 Million	-0.365x	-73.20%
2015-12-31	CHF106.25 Million ≈ $134.32 Million	CHF-22.39 Million ≈ $-28.31 Million	-0.211x	+40.08%
2014-12-31	CHF17.24 Million ≈ $21.79 Million	CHF-6.06 Million ≈ $-7.67 Million	-0.352x	+64.17%
2013-12-31	CHF7.11 Million ≈ $8.98 Million	CHF-6.98 Million ≈ $-8.82 Million	-0.982x	-4.32%
2012-12-31	CHF11.73 Million ≈ $14.83 Million	CHF-11.04 Million ≈ $-13.96 Million	-0.941x	-103.34%
2011-12-31	CHF42.98 Million ≈ $54.34 Million	CHF-19.89 Million ≈ $-25.15 Million	-0.463x	-385.61%
2010-12-31	CHF69.63 Million ≈ $88.03 Million	CHF-6.64 Million ≈ $-8.39 Million	-0.095x	+61.65%
2009-12-31	CHF83.51 Million ≈ $105.58 Million	CHF-20.75 Million ≈ $-26.24 Million	-0.249x	+43.18%
2008-12-31	CHF104.47 Million ≈ $132.08 Million	CHF-45.69 Million ≈ $-57.77 Million	-0.437x	-164.92%
2007-12-31	CHF135.51 Million ≈ $171.33 Million	CHF-22.37 Million ≈ $-28.28 Million	-0.165x	-1.08%
2006-12-31	CHF152.05 Million ≈ $192.23 Million	CHF-24.83 Million ≈ $-31.40 Million	-0.163x	--

About Santhera Pharmaceuticals Holding AG

SW:SANN Switzerland Biotechnology

Market Cap

$252.05 Million

CHF199.37 Million CHF

Market Cap Rank

#15719 Global

#170 in Switzerland

Share Price

CHF14.02

Change (1 day)

-0.99%

52-Week Range

CHF9.58 - CHF18.54

All Time High

CHF1070.00